IMPRESSION – A randomised trial to evaluate the efficacy of MagicTouch Sirolimus Coated Balloon in Dysfunctional Fistula progresses rapidly

Concept Medical Inc., focused on vascular intervention drug delivery devices, has updated the progress of IMPRESSION (sIroliMus coated balloon angioPlasty versus plain balloon angioplasty in the tREatment of dialySis acceSs dysfunctION) randomised trial. IMPRESSION is a prospective, multi-center, two-arm parallel group, randomised clinical trial to compare the efficacy of Sirolimus Coated Balloon versus Placebo Plain Balloon (control arm) in…

thaipr.net

24 มิ.ย. 64

Valcon Medical A/S Announces Receipt of EU GMP Certification and Start of Commercial Production for Pharmaceutical-Grade Cannabis Concentrates, Intermediary Products, and Medical Formulations

Valcon Medical A/S (“Valcon Medical” or the “Company”), Denmark’s leading independent cannabis concentrate and medical formulation provider, received its licensing for the commercial production of cannabis from the Danish Medicines Agency (DKMA) earlier in May 2021. Under the DKMA licensing, Valcon Medical is authorized to produce medical cannabis in accordance with section 9(1) of the […]

thaipr.net

23 มิ.ย. 64

Alfasigma acquires the European license for bentracimab from PhaseBio

— The agreement covers the countries of the European Union, the European Economic Area, the United Kingdom, Ukraine, Russia and the CIS — Bentracimab is a human monoclonal antibody fragment to counteract the antiplatelet effects of ticagrelor — After the recent acquisition of Lumeblue®, Alfasigma’s pipeline is enriched with a biotechnological drug Alfasigma has entered into […]

thaipr.net

22 มิ.ย. 64

RedHill Biopharma Announces Presentation of Positive Oral Opaganib Phase 2 Data in COVID-19

Positive U.S. Phase 2 safety and efficacy data for opaganib, a leading novel, oral, dual-mechanism drug candidate for moderate-to-severe COVID-19, presented at the World Microbe Forum Opaganib was associated with a reduction in the need for supplemental oxygen support, earlier time to discharge from hospital and was well tolerated Opaganib’s global 475-patient Phase 2/3 study […]

thaipr.net

22 มิ.ย. 64

INDICAID(R) COVID-19 Rapid Antigen Test certified by Cambodia’s Ministry of Health for Disease Control

Cambodia’s Ministry of Health has approved INDICAID® COVID-19 Rapid Antigen Test for commercialisation as part of the country’s efforts in controlling recent spikes of COVID-19 cases in the region. Rapid antigen tests like INDICAID® have been deployed by the Cambodian Government for widescale screening measures in the capital city Phnom Penh and neighbouring regions, taking […]

thaipr.net

22 มิ.ย. 64

EAN Congress: COVID-19 leads to significant cognitive and behavioural problems in patients

COVID-19 patients suffer from cognitive and behavioural problems two months after being discharged from hospital, a new study presented at the 7th Congress of the European Academy of Neurology has found [1]. Issues with memory, spatial awareness and information processing problems were identified as possible overhangs from the virus in post-COVID-19 patients who were followed up […]

thaipr.net

21 มิ.ย. 64
1 107 108 109 110 111 128